Cargando…
The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy()
INTRODUCTION: Brain metastases are frequently treated with stereotactic radiosurgery (SRS). Radionecrosis (RN) is the late side effect in up to 24% of patients, being symptomatic in 8–10%. Fixed values of the radiosurgical volume receiving 12 Gy or more (V12Gy) are used to roughly predict the global...
Autores principales: | Daisne, Jean-François, De Ketelaere, Clémentine, Jamart, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829108/ https://www.ncbi.nlm.nih.gov/pubmed/33532633 http://dx.doi.org/10.1016/j.ctro.2021.01.003 |
Ejemplares similares
-
The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis
por: Delishaj, Durim, et al.
Publicado: (2015) -
Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases
por: Peng, Luke, et al.
Publicado: (2019) -
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
por: Minniti, Giuseppe, et al.
Publicado: (2011) -
Symptomatic radionecrosis after postoperative but not preoperative stereotactic radiosurgery in a single patient: illustrative case
por: Laurin, Bryce J, et al.
Publicado: (2023) -
Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery
por: Devan, Sean P., et al.
Publicado: (2022)